So essentially plan for failure? Working in the industry, I can tell you that's not how it's done. Ever.
If BIEL does get FDA clearance, and it's a skeleton crew...what happens then?
All companies gear up as if approval/clearance is coming. They need to, because every day wasted when your product is approved/cleared and it's not on the shelves is big money.
For an investor, sure, we'd like them to shut down, have them not dilute as much, then get clearance and we can sell, leaving them to figure the rest out. But operating a business in this industry does not work like that. If approval comes and they have to spend an extra month bringing staff back on, etc...how much money does that equate in loss? How much PPS drop?
They are also supporting new studies for new applications of PEMF...if they did not do this until clearance came, where would they be for the future.
This industry is a gamble, for both investors and companies. And you go all in, every time. Win some, lose some, but you must plan for success.
I don't disagree that PEMF therapy is not popular..however it's time is coming, but without advertising or some kind of momentum, it will take much longer. CAN launch is one way to get the advertising out there. Without that, ANY product is dead, not just PEMF.
Besides, once the apps are in, they cannot 'focus more money on clearance'. It's essentially reacting to the FDA this point.
Market Data 
Markets 
